Skip to main content

Midland States Bancorp, Inc.

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

MSBI$32.44+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm (PCAOB ID 173)55
Consolidated Balance Sheets56
Consolidated Statements of Income57
Consolidated Statements of Comprehensive Income58
Consolidated Statements of Shareholders' Equity59
Consolidated Statements of Cash Flows60
Note 1. Summary of Significant Accounting Policies61
Note 2. Investment Securities71
Note 3. Loans73
Note 4. Premises, Equipment and Leases90
Note 5: Operating Leases - Lessor91
Note 6. Loan Servicing Rights91
Note 7. Goodwill and Intangible Assets92
Note 8. Derivative Instruments93
Note 9. Deposits96
Note 10. FHLB Advances96
Note 11. Subordinated Debt97
Note 12. Trust Preferred Debentures98
Note 13. Accumulated Other Comprehensive Income (Loss)99
Note 14. Income Taxes100
Note 15. Retirement Plans102
Note 16. Share-Based Compensation104
Note 17. Preferred Stock106
Note 18. Earnings Per Common Share107
Note 19. Capital Requirements107
Note 20. Fair Value of Financial Instruments108
Note 21. Commitments, Contingencies and Credit Risk114
Note 22. Segment Information114
Note 23. Revenue from Contracts with Customers117
Note 24. Parent Company Only Financial Information118

Shareholders and the Board of Directors of Midland States Bancorp, Inc.

Effingham, Illinois

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Midland States Bancorp, Inc. (the "Company") as of December 31, 2025 and 2024, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). We also have audited the Company’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control – Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2025 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control – Integrated Framework: (2013) issued by COSO.

Basis for Opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

As described in Notes 1 and 3 to the consolidated financial statements, the Allowance for Credit Losses on Loans (“ACL”) represents the Company’s estimate of expected credit losses over the contractual life of loans held for investment. The estimate is based on historical loss experience, current conditions, and reasonable and supportable forecasts. As of December 31, 2025, the Company’s ACL was $69.2 million, and the provision for credit losses on loans was $60.5 million for the year then ended.

The Company estimates expected credit losses using a quantitative model and qualitative adjustments. The quantitative component is based on a probability of default, loss given default, and exposure at default framework that incorporates historical default experience, loan-level risk characteristics, and forecasted macroeconomic variables over a reasonable and supportable forecast period, with losses reverting to long-term historical averages thereafter. The macroeconomic variables used in the model are selected based on statistical relevancy and correlation to historical credit losses by performing regression analyses. Management then applies qualitative factor adjustments to the modeled results for risks not fully captured in the model, including changes in economic and business conditions, portfolio credit quality, delinquency and nonaccrual trends, collateral values, and other internal and external factors.

We identified auditing the allowance for credit losses on loans, including the selection and application of forecasted macroeconomic variables and qualitative factor adjustments, as a critical audit matter. Auditing these judgments involved a high degree of auditor judgment and significant audit effort to evaluate the significant subjective and complex judgments made by management throughout the application processes for the forecasted macroeconomic variables and qualitative factor adjustments, including the need to involve our valuation services specialists.

The primary audit procedures we performed to address this critical audit matter included:

Testing the operating effectiveness of the Company’s controls over the:

Selection and application of forecasted macroeconomic variables and related forecast scenarios.

Review of the reasonableness of the calculation output and tested the completeness and accuracy of inputs used in the quantitative model and qualitative factor adjustments.

Review over the relevance and reliability of external data used in the analysis to select the forecasted macroeconomic variables and qualitative factor adjustments.

Review over the appropriateness of the framework for the qualitative factor adjustments.

Mathematical accuracy of the qualitative factor adjustments.

Substantive tests included:

Evaluating the relevance and reliability of the external data used in the selection of forecasted macroeconomic variables.

Evaluating the reasonableness of the selection and application of the forecasted macroeconomic variables and scenarios used in the reasonable and supportable forecast period.

Testing the completeness and accuracy of inputs used in the quantitative model and evaluating the reasonableness of the calculation output.

Assessing the appropriateness and reasonableness of the framework developed for the qualitative factor adjustments including evaluating management’s judgments as to which factors impacted the qualitative analysis for each portfolio segment.

Testing the completeness and accuracy of internal data and relevance and reliability of external data used in determining the qualitative factor adjustments.

Testing the mathematical accuracy of the calculation of the qualitative factor adjustments.

Credit Enhancements Contained Within Third-Party Agreements

The Company has an agreement with a third party to originate and service consumer and commercial loans that are included in the Company’s loan portfolio as described in Notes 1 and 3 to the consolidated financial statements. The Company recorded a credit enhancement asset of $12.6 million as of December 31, 2025 related to the agreement associated with loans recorded on the balance sheet as of December 31, 2025. The Company also recorded a $12.6 million allowance for credit losses for these consumer and commercial loans as of December 31, 2025.

We identified auditing the accounting associated with the credit enhancement contained within the third-party agreements as a critical audit matter due to the nature and extent of audit effort required, including the need for individuals with specialized knowledge.

The primary procedures we performed to address this critical audit matter included engaging our internal specialists to evaluate the third-party agreement and the related accounting treatment; and testing the operating effectiveness of the control over the evaluation of the accounting and financial reporting impact related to this third-party agreement.

Crowe LLP

We have served as the Company’s auditor since 2017.

Oakbrook Terrace, Illinois

March 2, 2026

CONSOLIDATED BALANCE SHEETS

December 31,2025December 31,2024
Assets
Cash and due from banks$127,279$114,055
Federal funds sold532711
Cash and cash equivalents127,811114,766
Investment securities available for sale, at fair value1,523,0011,207,574
Equity securities, at fair value4,2354,792
Loans4,352,0045,167,574
Allowance for credit losses on loans(69,219)(111,204)
Total loans, net4,282,7855,056,370
Loans held for sale7,781344,947
Premises and equipment, net85,13485,710
Other real estate owned6064,941
Nonmarketable equity securities32,59833,723
Accrued interest receivable23,82425,329
Loan servicing rights, at lower of cost or fair value11,93217,842
Loan servicing rights, held for sale3,661—
Goodwill7,927161,904
Other intangible assets, net8,87612,100
Company-owned life insurance218,554211,168
Credit enhancement asset12,55716,804
Other assets162,138208,839
Total assets$6,513,420$7,506,809
Liabilities and Shareholders’ Equity
Liabilities:
Deposits:
Noninterest-bearing demand deposits$1,040,411$1,055,564
Interest-bearing deposits4,383,9685,141,679
Total deposits5,424,3796,197,243
Short-term borrowings60,18187,499
Federal Home Loan Bank advances293,000258,000
Subordinated debt27,01977,749
Trust preferred debentures51,85751,205
Accrued interest payable and other liabilities91,485124,266
Total liabilities5,947,9216,795,962
Shareholders’ Equity:
Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at December 31, 2025 and December 31, 2024, respectively110,548110,548
Common stock, $0.01 par value; 40,000,000 shares authorized; 21,169,854 and 21,494,485 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively212215
Capital surplus428,247434,346
Retained earnings86,825247,698
Accumulated other comprehensive loss, net of tax(60,333)(81,960)
Total shareholders’ equity565,499710,847
Total liabilities and shareholders’ equity$6,513,420$7,506,809

CONSOLIDATED STATEMENTS OF INCOME

Years Ended December 31,
202520242023
Interest income:
Loans including fees:
Taxable$310,169$365,892$378,333
Tax exempt1,6511,5361,764
Loans held for sale5,232392260
Investment securities:
Taxable63,24849,76928,653
Tax exempt1,7531,5111,349
Nonmarketable equity securities2,7293,0702,819
Federal funds sold and cash investments3,0853,9583,922
Total interest income387,867426,128417,100
Interest expense:
Deposits124,271160,676136,947
Short-term borrowings2,8071,96068
Federal Home Loan Bank advances14,62116,49520,709
Subordinated debt4,5545,2715,266
Trust preferred debentures4,8105,3805,289
Total interest expense151,063189,782168,279
Net interest income236,804236,346248,821
Provision for credit losses:
Provision for credit losses on loans60,549119,26282,560
(Recapture of) provision for credit losses on unfunded commitments(700)1,070—
Total provision for credit losses59,849120,33282,560
Net interest income after provision for credit losses176,955116,014166,261
Noninterest income:
Wealth management revenue31,01928,69725,572
Service charges on deposit accounts13,82713,15411,990
Interchange revenue13,49613,95514,302
Residential mortgage banking revenue2,8572,4181,903
Income on company-owned life insurance8,5647,6834,439
Gain (loss) on sales of investment securities, net14(230)(9,372)
Credit enhancement income9,90460,99848,194
Other income8,49912,06617,756
Total noninterest income88,180138,741114,784
Noninterest expense:
Salaries and employee benefits104,40093,63993,438
Occupancy and equipment17,22316,78515,986
Data processing27,97428,16026,286
FDIC insurance8,1365,2784,779
Professional services9,8717,8227,049
Marketing5,8613,9263,158
Communications1,3761,3641,741
Loan expense6,9925,9544,206
Loan servicing fees4,57812,86419,181
Impairment on goodwill153,977——
Amortization of intangible assets3,2244,0084,758
Other real estate owned2815,569333
Loss on sale of loan portfolios23,051——
Impairment on leased assets and surrendered assets6847,858—
Other expense12,37514,62812,168
Total noninterest expense380,003207,855193,083
Income (loss) before income taxes(114,868)46,90087,962
Income tax expense9,4138,85626,807
Net income (loss)(124,281)38,04461,155
Preferred dividends8,9138,9138,913
Net income (loss) available to common shareholders$(133,194)$29,131$52,242
Per common share data:
Basic earnings (loss) per common share$(6.12)$1.32$2.33
Diluted earnings (loss) per common share$(6.12)$1.32$2.33
Weighted average common shares outstanding21,833,09821,731,68922,115,869
Weighted average diluted common shares outstanding21,833,09821,737,95822,124,402

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(dollars in thousands)

Years Ended December 31,
202520242023
Net income (loss)$(124,281)$38,044$61,155
Other comprehensive income (loss):
Investment securities available for sale:
Unrealized gains that occurred during the period27,421(9,278)(2,536)
Reclassification adjustment for realized net (gains) losses on sales of investment securities included in net income(14)2309,372
Reclassification adjustment for gains on fair value hedges included in net income—(142)—
Income tax effect(7,603)1,677(1,845)
Change in investment securities available for sale, net of tax19,804(7,513)4,991
Cash flow hedges:
Net unrealized derivative gains (losses) on cash flow hedges1,730(1,692)(2,452)
Reclassification adjustment for net losses realized in net income6934,8915,264
Income tax effect(600)(893)(759)
Change in cash flow hedges, net of tax1,8232,3062,053
Other comprehensive income (loss), net of tax21,627(5,207)7,044
Total comprehensive income (loss)$(102,654)$32,837$68,199

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

Preferred stockCommonstockCapitalsurplusRetainedearningsAccumulatedothercomprehensiveincome (loss)Totalshareholders'equity
Balances, December 31, 2022$110,548$222$449,196$219,970$(83,797)$696,139
Net income———61,155—61,155
Other comprehensive income————7,0447,044
Issuance of preferred stock, net of offering costs——————
Common dividends declared ($1.20 per share)———(26,573)—(26,573)
Preferred dividends———(8,913)—(8,913)
Common stock repurchased—(8)(17,890)——(17,898)
Share-based compensation expense——2,489——2,489
Issuance of common stock under employee benefit plans—21,668——1,670
Balances, December 31, 2023$110,548$216$435,463$245,639$(76,753)$715,113
Net income———38,044—38,044
Other comprehensive loss————(5,207)(5,207)
Common dividends declared ($1.24 per share)———(27,072)—(27,072)
Preferred dividends———(8,913)—(8,913)
Common stock repurchased—(2)(5,473)——(5,475)
Share-based compensation expense——3,031——3,031
Issuance of common stock under employee benefit plans—11,325——1,326
Balances, December 31, 2024$110,548$215$434,346$247,698$(81,960)$710,847
Net loss———(124,281)—(124,281)
Other comprehensive income————21,62721,627
Common dividends declared ($1.26 per share)———(27,679)—(27,679)
Preferred dividends———(8,913)—(8,913)
Common stock repurchased—(4)(9,654)——(9,658)
Share-based compensation expense——2,913——2,913
Issuance of common stock under employee benefit plans—1642——643
Balances, December, 31, 2025$110,548$212$428,247$86,825$(60,333)$565,499

CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

Years Ended December 31,
202520242023
Cash flows from operating activities:
Net income (loss)$(124,281)$38,044$61,155
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses59,849120,33282,560
Depreciation on premises and equipment4,8924,9934,778
Impairment on goodwill153,977——
Amortization of intangible assets3,2244,0084,758
Amortization of operating lease right-of-use asset1,5701,6571,635
Amortization of loan servicing rights2,2662,4981,550
Share-based compensation expense2,9133,0312,489
Increase in cash surrender value of life insurance(8,209)(7,683)(4,439)
Gain on proceeds from company-owned life insurance(343)——
Investment securities accretion, net(13,696)(6,789)(2,414)
(Gain) loss on sales of investment securities, net(14)2309,372
Gain on repurchase of subordinated debt—(231)(676)
Gain on sales of other real estate owned(124)(26)(819)
Impairment on other real estate owned—4,866—
Origination of loans held for sale(101,211)(81,077)(58,953)
Proceeds from sales of loans and leases held for sale133,53478,51457,952
Gain on sale of loans held for sale(2,560)(2,307)(2,395)
Loss on mortgage servicing rights held for sale(18)—
Loss on sale of loan portfolios23,051——
Impairment on leased assets and surrendered assets6847,858—
Net change in operating assets and liabilities:
Accrued interest receivable1,5058,804(4,360)
Credit enhancement asset4,247(1,415)(2,376)
Other assets24,483(16,783)(24,038)
Accrued expenses and other liabilities(40,060)18,02227,579
Net cash provided by operating activities125,679176,546153,358
Cash flows from investing activities:
Purchases of investment securities available for sale(622,913)(605,169)(412,799)
Proceeds from sales of investment securities available for sale103,75874,116191,733
Maturities and payments on investment securities available for sale248,991233,56374,531
Purchases of equity securities(174)(268)(286)
Proceeds from sales of equity securities——5,148
Net decrease in loans438,907346,88372,877
Proceeds from sales of consumer loans held for sale61,099——
Proceeds from sales of loan portfolios517,43084,28340,899
Purchases of premises and equipment(5,346)(6,901)(8,731)
Proceeds from sale of premises and equipment—37104
Purchases of nonmarketable equity securities(186,124)(172,057)(239,597)
Proceeds from redemptions of nonmarketable equity securities187,249181,755242,377
Proceeds from sales of other real estate owned4,8624667,547
Proceeds from company-owned life insurance, net1,166—(48,603)
Net cash provided by (used in) investing activities748,905136,708(74,800)
Cash flows from financing activities:
Net decrease in deposits(772,864)(112,286)(55,123)
Net increase (decrease) in short-term borrowings(27,318)52,634(7,446)
Net increase (decrease) in short-term FHLB advances(20,000)(166,000)(174,000)
Proceeds from long-term FHLB advances328,000263,000215,000
Payments made on long-term FHLB advances and other borrowings(273,000)(315,000)(25,000)
Payments and subordinated debt redemption(50,750)(15,763)(5,845)
Cash dividends paid on preferred stock(8,913)(8,913)(8,913)
Cash dividends paid on common stock(27,679)(27,072)(26,573)
Common stock repurchased(9,658)(5,475)(17,898)
Proceeds from issuance of common stock under employee benefit plans6431,3261,670
Net cash used in financing activities(861,539)(333,549)(104,128)
Net increase (decrease) in cash and cash equivalents13,045(20,295)(25,570)
Cash and cash equivalents:
Beginning of period114,766135,061160,631
End of period$127,811$114,766$135,061

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.